{"parse":{"title":"Qualified Person Responsible For Pharmacovigilance","pageid":25212610,"revid":834366854,"text":{"*":"<div class=\"mw-parser-output\"><div role=\"note\" class=\"hatnote navigation-not-searchable\">Not to be confused with <a href=\"/wiki/Qualified_person_(European_Union)\" title=\"Qualified person (European Union)\">Qualified person (European Union)</a>.</div>\n<p>In the European Union, the <b>Qualified Person Responsible For Pharmacovigilance</b> (<b>QPPV</b>) is an individual, usually an employee of a pharmaceutical company, who is personally responsible for the safety of the human pharmaceutical products marketed by that company in the EU. This function was established in 2004 by article 23 of regulation (EC) No 726/2004. The article establishes that the holder of a marketing authorization for a drug for human use must have a QPPV. When a company submits an application for permission to bring a medicinal product onto the market, the company submits a description of its system for monitoring the safety of the product in actual use (a <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a> system) and proof that the services of a QPPV are in place.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p><p>\"The holder of an authorisation for a medicinal product for human use granted in accordance with the provisions of this Regulation shall have permanently and continuously at his disposal an appropriately qualified person responsible for pharmacovigilance.\"\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Responsibilities\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Responsibilities</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Criteria_for_QPPV_role\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Criteria for QPPV role</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#See_also\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Responsibilities\">Responsibilities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit&amp;section=1\" title=\"Edit section: Responsibilities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Per Article 23, the QPPV is responsible for:\n</p>\n<ol><li>Establishing and maintaining a pharmacovigilance system</li>\n<li>Preparing pharmacovigilance reports as defined by regulations</li>\n<li>Answering requests from Health Authorities</li>\n<li>Providing Health Authorities with any other information relevant to product safety</li></ol>\n<p>Volume 9A provides further guidance regarding these responsibilities of the QPPV (Part I, Chapter 1.2, Section 1.2.1: The Role and Responsibilities of the Qualified Person Responsible for Pharmacovigilance). Per Volume 9A, the QPPV is responsible for \"overall pharmacovigilance for all medicinal products for which the company holds marketing authorisations within the EU\", and specifically for:\n</p>\n<ul><li>Establishing and maintaining/managing the pharmaceutical company's pharmacovigilance system</li>\n<li>Having an overview of the safety profiles and any emerging safety concerns for the company's drugs</li>\n<li>Acting as a single contact point for the Health Authorities on a 24-hour basis</li></ul>\n<h2><span class=\"mw-headline\" id=\"Criteria_for_QPPV_role\">Criteria for QPPV role</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit&amp;section=2\" title=\"Edit section: Criteria for QPPV role\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The QPPV must reside in the EU, and should be permanently and continuously at the disposal of the MAH. Each company (i.e. Applicant/Marketing Authorisation Holder or group of Marketing Authorisation Holders using a common pharmacovigilance system) should appoint one QPPV responsible for overall pharmacovigilance for all medicinal products for which the company holds marketing authorisations within the <a href=\"/wiki/European_Union\" title=\"European Union\">EU</a>.\n</p><p>Detailed information on the role and responsibilities of the QPPV, and guidance for a Marketing Authorisation Holder on how to adequately support the QPPV are specified in Guideline on good pharmacovigilance practices (GVP; Module I \u2013 Pharmacovigilance systems and their quality systems).\"<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>   At a minimum the QPPV should be appropriately <a href=\"/wiki/Professional_certification\" title=\"Professional certification\">qualified</a>, with documented experience in all aspects of pharmacovigilance in order to fulfil the responsibilities and tasks of the post. If the QPPV is not medically qualified, access to a <a href=\"/wiki/Medical_credentials\" title=\"Medical credentials\">medically qualified person</a> should be available.\n</p><p>In addition, there are national regulations in some <a href=\"/wiki/Member_state_of_the_European_Union\" title=\"Member state of the European Union\">EU member states</a> that also require a nominated individual in that country who has specific legal obligations as a QPPV at a national level.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit&amp;section=3\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a></li>\n<li><a href=\"/wiki/European_Medicines_Agency\" title=\"European Medicines Agency\">European Medicines Agency</a></li>\n<li><a href=\"/wiki/EudraLex\" title=\"EudraLex\">EudraLex</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\">See <a rel=\"nofollow\" class=\"external text\" href=\"http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_cons2009/2001_83_cons2009_en.pdf\">Article 8(3)(ia) of Directive 2001/83/EC</a> </span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\">EudraLex - <a rel=\"nofollow\" class=\"external text\" href=\"http://ec.europa.eu/health/documents/eudralex/vol-9/index_en.htm\">Volume 9 Pharmacovigilance Guidelines</a></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf\">REGULATION (EC) No 726/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20091114181917/http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/vol9a_09-2008.pdf\">Volume 9 of \u201cThe rules governing medicinal products in the European Union\u201d contains Pharmacovigilance guidelines for medicinal products for both human and veterinary use.</a></li></ul>\n<table class=\"metadata plainlinks stub\" role=\"presentation\" style=\"background:transparent\"><tbody><tr><td><a href=\"/wiki/File:Coupe_d%27Hygie.svg\" class=\"image\"><img alt=\"Stub icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Coupe_d%27Hygie.svg/40px-Coupe_d%27Hygie.svg.png\" width=\"40\" height=\"48\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Coupe_d%27Hygie.svg/60px-Coupe_d%27Hygie.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1a/Coupe_d%27Hygie.svg/80px-Coupe_d%27Hygie.svg.png 2x\" data-file-width=\"354\" data-file-height=\"427\" /></a></td><td><i>This <a href=\"/wiki/Pharmacy\" title=\"Pharmacy\">pharmacy</a>-related article is a <a href=\"/wiki/Wikipedia:Stub\" title=\"Wikipedia:Stub\">stub</a>. You can help Wikipedia by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Qualified_Person_Responsible_For_Pharmacovigilance&amp;action=edit\">expanding it</a>.</i><div class=\"plainlinks hlist navbar mini\" style=\"position: absolute; right: 15px; display: none;\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pharmacy-stub\" title=\"Template:Pharmacy-stub\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pharmacy-stub\" title=\"Template talk:Pharmacy-stub\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Pharmacy-stub&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw1270\nCached time: 20180907034740\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.064 seconds\nReal time usage: 0.083 seconds\nPreprocessor visited node count: 84/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 2926/2097152 bytes\nTemplate argument size: 0/2097152 bytes\nHighest expansion depth: 3/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 860/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.021/10.000 seconds\nLua memory usage: 801 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   57.913      1 -total\n 61.59%   35.669      1 Template:Distinguish\n 30.51%   17.671      1 Template:Pharmacy-stub\n 27.31%   15.819      1 Template:Asbox\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:25212610-0!canonical and timestamp 20180907034740 and revision id 834366854\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Clinical_research_ethics"},{"sortkey":"","*":"Pharmaceuticals_policy"},{"sortkey":"","*":"Healthcare_quality"},{"sortkey":"","*":"Drug_safety"},{"sortkey":"","hidden":"","*":"All_stub_articles"},{"sortkey":"","*":"Pharmacology_stubs"}],"links":[{"ns":10,"exists":"","*":"Template:Pharmacy-stub"},{"ns":0,"exists":"","*":"EudraLex"},{"ns":0,"exists":"","*":"European Medicines Agency"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Medical credentials"},{"ns":0,"exists":"","*":"Member state of the European Union"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Pharmacy"},{"ns":0,"exists":"","*":"Professional certification"},{"ns":0,"exists":"","*":"Qualified person (European Union)"},{"ns":4,"exists":"","*":"Wikipedia:Stub"},{"ns":11,"exists":"","*":"Template talk:Pharmacy-stub"}],"templates":[{"ns":10,"exists":"","*":"Template:Distinguish"},{"ns":10,"exists":"","*":"Template:Pharmacy-stub"},{"ns":10,"exists":"","*":"Template:Asbox"},{"ns":828,"exists":"","*":"Module:Distinguish"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Asbox"},{"ns":828,"exists":"","*":"Module:Buffer"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Coupe_d'Hygie.svg"],"externallinks":["http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_cons2009/2001_83_cons2009_en.pdf","http://ec.europa.eu/health/documents/eudralex/vol-9/index_en.htm","http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf","https://web.archive.org/web/20091114181917/http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/vol9a_09-2008.pdf"],"sections":[{"toclevel":1,"level":"2","line":"Responsibilities","number":"1","index":"1","fromtitle":"Qualified_Person_Responsible_For_Pharmacovigilance","byteoffset":1226,"anchor":"Responsibilities"},{"toclevel":1,"level":"2","line":"Criteria for QPPV role","number":"2","index":"2","fromtitle":"Qualified_Person_Responsible_For_Pharmacovigilance","byteoffset":2218,"anchor":"Criteria_for_QPPV_role"},{"toclevel":1,"level":"2","line":"See also","number":"3","index":"3","fromtitle":"Qualified_Person_Responsible_For_Pharmacovigilance","byteoffset":3663,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"Qualified_Person_Responsible_For_Pharmacovigilance","byteoffset":3750,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Qualified_Person_Responsible_For_Pharmacovigilance","byteoffset":3781,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Qualified Person Responsible For Pharmacovigilance","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q7268654"}]}}